Cited by 1,589COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction

The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Open access

Dai, Mengyuan, Liu, Dianbo, Liu, Miao, Zhou, Fuxiang, Li, Guiling, Chen, Zhen, Zhang, Zhian, You, Hua, Wu, Meng, Zheng, Qichao, Xiong, Yong, Xiong, Huihua, Wang, Chun, Chen, Changchun, Xiong, Fei, Zhang, Yan, Peng, Yaqin, Ge, Siping, Zhen, Bo, Yu, Tingting, Wang, Ling, Wang, Hua, Liu, Yu, Chen, Yeshan, Mei, Junhua, Gao, Xiaojia, Li, Zhuyan, Gan, Lijuan, He, Can, Li, Zhen, Shi, Yuying, Qi, Yuwen, Yang, Jing, Tenen, Daniel G., Chai, Li, Mucci, Lorelei A., Santillana, Mauricio, Cai, Hongbing·2020·Cancer Discovery

DOI 10.1158/2159-8290.cd-20-0422PMC PMC7309152

Open this paper in CoChat — free account Open PDF

Abstract

Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-0422

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citation
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Multiple myeloma
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040

Show all 27 references

Sorted by citations

Items 701–800 of 1,001

Treatment of COVID-19 in Hemodialysis Patients Using Traditional Chinese Medicine: A Single-Center, Retrospective Study
Huang, W. C., Jiang, B., Luo, J., Luo, M., Ding, X., Yang, Q., Zhao, L., Sun, Q., & Tong, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.764305 · Cited by 7
Long non‐coding RNAs in virus‐related cancers
Huang, Y., Jiang, L., Liu, Y., Liu, L., Wang, J., & Shi, L. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2364 · Cited by 7
Self-citation
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
Nakashima, K., Ishida, M., Matsui, H., Yoshida, C., Nagai, T., Shiraga, M., Nakaoka, H., Otsuka, Y., Nakagama, Y., Kaku, N., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2140549 · Cited by 7
A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study
Chang, C., Meng, L., Li, X., Cheng, K., Cheng, Y., Peng, B., Ma, J., & Cao, D. (2022) · Cancer Control · doi:10.1177/10732748221141233 · Cited by 7
COVID-19 in Patients with Hematologic Diseases
Casetti, I. C., Borsani, O., & Rumi, E. (2022) · Biomedicines · doi:10.3390/biomedicines10123069 · Cited by 8
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
Piening, A., Ebert, E. C., Khojandi, N., Alspach, E., & Teague, R. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022732 · Cited by 7
An Impact of COVID-19 on Cancer Care: An Update
Chavda, V. P., Ping, F., & Chen, Z. (2022) · Vaccines · doi:10.3390/vaccines10122072 · Cited by 7
Self-citation
Translation, cultural adaptation and pilot testing of a questionnaire measuring the factors affecting the acceptance of telemedicine by Greek cancer patients
Papachristou, N., Vasileios, R., Sarafis, P., & Bamidis, P. D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278758 · Cited by 7
Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
Sayahinouri, M., Firouz, S. M., Sadrabadi, A. E., Masoudnia, M., Abdolahi, M., Jafarzadeh, F., Nouripour, M., Mirzazadeh, S., Zangeneh, N., Jalili, A., et al. (2023) · Bioimpacts · doi:10.34172/bi.2023.23839 · Cited by 8
Serious Clinical Outcomes of COVID-19 Related to Acetaminophen or NSAIDs from a Nationwide Population-Based Cohort Study
Kim, J.-W., Yoon, S., Lee, J. H., & Lee, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20053832 · Cited by 7
Identifying diseases associated with Post-COVID syndrome through an integrated network biology approach
Krishna, N., Sijina, K. P., & Rajanikant, G. K. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2195003 · Cited by 9
Baseline gut microbiome features prior to SARS‐CoV‐2 infection are associated with host symptoms in and post COVID‐19
Zuo, T., Liang, G., Huang, Z., Cao, Z., Bai, F., Zhou, Y., Wu, X., Wu, X., Chen, Y., Balati, M., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29083 · Cited by 7
Self-citation
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19
Reidy‐Lagunes, D. L., Saltz, L. B., Postow, M. A., Scordo, M., Moskowitz, A. J., Tew, W. P., Zamarin, D., & Redelman‐Sidi, G. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa111 · Cited by 7
COVID ‐19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion
Tse, K. Y., Domingo, E. J., Konar, H., Kumarasamy, S., Pariyar, J., Tjokroprawiro, B. A., Ushijima, K., Inthasorn, P., Tan, A. L., & Wilailak, S. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14579 · Cited by 7
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data
Pérez‐Segura, P., Paz-Cabezas, M., Nuñez-Gil, I. J., Arroyo‐Espliguero, R., Eid, C. M., Romero, R., Rozas, I. F., Uribarri, A., Becerra‐Muñoz, V. M., Aguado, M. G., et al. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.02.010 · Cited by 7
The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID‐19 patients with malignancy: A single‐center experience
Değerli, E., Derin, S., Oruç, K., Samancı, N. Ş., Bedir, Ş., Çelik, E., Öztaş, N. Ş., Alkan, G., Demirelli, F. H., & Demirci, N. S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27123 · Cited by 7
Business as unusual: medical oncology services adapt and deliver during COVID ‐19
Travers, A., Adler, K., Blanchard, G., Bonaventura, T., Charlton, J. A., Day, F. L., Healey, L., Kim, S., Lombard, J. M., Mallesara, G., et al. (2021) · Internal Medicine Journal · doi:10.1111/imj.15217 · Cited by 7
Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma
Levi, G., Rocchetti, C., Magri, R., Uccelli, S., Bottone, D., Quadri, F., Novali, M., Santin, A. D., & Bezzi, M. (2021) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2021.1867 · Cited by 7
Clinical characteristics and clinical predictors of mortality in hospitalised patients of COVID 19 : An Indian study
Padmaprakash, K. V., Vardhan, V., Thareja, S., Muthukrishnan, J., Raman, N., Ashta, K. K., Rana, S., Kishore, K., & Nauhwaar, D. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.01.009 · Cited by 7
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
Sacconi, A., Vitis, C. D., de Latouliere, L., Martino, S. D., Nicola, F. D., Goeman, F., Mottini, C., Paolini, F., D’Ascanio, M., Rícci, A., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04299-y · Cited by 7
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data
Pérez‐Segura, P., Paz-Cabezas, M., Nuñez-Gil, I. J., Arroyo‐Espliguero, R., Eid, C. M., Romero, R., Rozas, I. F., Uribarri, A., Becerra‐Muñoz, V. M., Aguado, M. G., et al. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.02.021 · Cited by 7
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
Body, A. L., Ahern, E. S., Lal, L., Gillett, K., Abdulla, H., Opat, S., O'Brien, T. A., Downie, P., Turville, S. G., Munier, C. M. L., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-021-07019-1 · Cited by 7
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic
Schwab, R. M., Droste, A., Stewen, K., Elger, T., Theis, S., Heimes, A.-S., Peters, K., Schmidt, M., Brenner, W., & Hasenburg, A. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s373191 · Cited by 6
Systemic therapy and COVID19: Immunotherapy and chemotherapy
Gulati, S., Muddasani, R., Bergerot, P. G., & Pal, S. K. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.12.022 · Cited by 7
Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
Hindilerden, İ. Y., Hindilerden, F., Mastanzade, M. G., Tiryaki, T. O., Tasan-Yenigun, S., Bilen, Y., Aksöz, S., Çağatay, A. A., & Nalçacı, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.601709 · Cited by 7
Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration
Palmieri, C., Palmer, D. H., Openshaw, P., Baillie, J. K., Semple, M. G., & Turtle, L. C. W. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000825 · Cited by 7
Challenges and recommendations for cancer care in the COVID-19 pandemic
Tian, J., & Miao, X. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0300 · Cited by 7
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
Titova, E., Kan, V. W., Lozy, T., Ip, A., Shier, K. L., Prakash, V. P., Starolis, M. W., Ansari, S., Goldgirsh, K., Kim, S., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02050-23 · Cited by 6
Effects of antibiotics on immunotherapy in patients with metastatic nonsmall cell lung cancer
Hu, T., Li, L., Cui, J., Song, X., Zhu, H., Hou, Z. W., & Yuan, S. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000912 · Cited by 6
Association between COVID-19 history and postoperative delirium in elderly patient undergoing elective surgery: a prospective, two-center observational cohort study
Duan, W., Yang, J.-J., Fang, P.-P., Zhu, W.-J., Zhang, Y., Li, X.-Y., Ma, D.-Q., Shan, Y.-Y., Liu, X., & Yang, J. (2025) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-025-00088-4 · Cited by 6
Self-citation
Burden of hematologic malignancies in China from 1990 to 2021: analysis from the Global Burden of Disease Study 2021
Shao, K., Wang, C., Chen, W., Gong, W., Lin, X., Ye, B., & Ye, D. (2025) · BMC Public Health · doi:10.1186/s12889-025-23469-7 · Cited by 6
Self-citation
COVID-19: The Impact in Oncology Care
Ray, U., Aziz, F., Shankar, A., Biswas, A. S., & Chakraborty, A. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00592-7 · Cited by 6
Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients
Chen, Y., Qin, Y., Fu, Y., Gao, Z., & Deng, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415698 · Cited by 6
Self-citation
The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age
Orillard, É., Spehner, L., Mansi, L., Bouard, A., Falcoz, A., Lepiller, Q., Renaude, E., Pallandre, J., Vienot, A., Kroemer, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160664 · Cited by 7
Effect of COVID-19 and Air Pollution on the Risk Factors Attributed to COPD, Cardiovascular, and Respiratory Diseases
Nikmanesh, Y., Zarea, K., Hatamzadeh, N., Cheraghi, M., Taherian, M., Jalali, S., Tahery, N., Shahriyari, H. A., Fard, A. Z., & Mohammadi, M. J. (2023) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-139881 · Cited by 6
COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review
Vinutha, M., Sharma, U., Swamy, G., Rohini, S., Vada, S., Janandri, S., Haribabu, T. E., Taj, N., Gayathri, S. V., Jyotsna, S., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123022 · Cited by 8
The Resilience of Radiation Oncology in the COVID Era and Beyond
Teckie, S., Koffler, D. M., & Potters, L. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.065 · Cited by 6
Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic.
Zhao, W., Qiu, H., Gong, Y., Chen, H., Ruan, S., Wang, C.-Y., Chen, J., Ke, S., Shi, W. K., Wang, J., et al. (2020) · PubMed Central · Cited by 6
Self-citation
Outcomes of Cancer Surgery During the COVID-19 Pandemic: Preparedness to Practising Continuous Cancer Care
Ramachandra, C., Sugoor, P., Karjol, U., Arjunan, R., Altaf, S. Y., Halkud, R., Krishnappa, R. L., Chavan, P., Siddappa, K., Shetty, R., et al. (2020) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-020-01250-z · Cited by 6
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Takahari, D., Shinozaki, E., Wakatsuki, T., Ooki, A., Ozaka, M., Suzuki, T., Nakayama, I., Osumi, H., Kamiimabeppu, D., Sato, T., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01806-7 · Cited by 7
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
Burgaletto, C., Brunetti, O., Munafò, A., Bernardini, R., Silvestris, N., Cantarella, G., & Argentiero, A. (2021) · Cancers · doi:10.3390/cancers13081906 · Cited by 6
Mortality from COVID-19 in patients with lung cancer
Kulkarni, A. A., Wilson, G. V., Fujioka, N., & Patel, M. R. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.36 · Cited by 6
Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?
Mustafa, D. A. M., Saida, L., Latifi, D., Wismans, L. V., de Koning, W., Zeneyedpour, L., Luider, T. M., van den Hoogen, B. G., & van Eijck, C. H. J. (2021) · Cancers · doi:10.3390/cancers13122896 · Cited by 6
Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients
Kiani, A., Roesch, R., Wendtner, C., Kullmann, F., Kubin, T., Südhoff, T., Augustin, M., Schaich, M. A., Müller‐Naendrup, C., Illerhaus, G., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4023 · Cited by 5
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
Ullgren, H., Camuto, A., Rosas, S., Pahnke, S., Ginman, B., Enblad, G., Glimelius, I. C., Fransson, P., Friesland, S., & Liu, L. L. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1958005 · Cited by 6
The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study
Lima, Á., de Sousa, H. M. L., Nobre, A., Faria, A. L., & Machado, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168552 · Cited by 6
Where Enhanced Recovery after Surgery (ERAS) Protocols Meet the Three Major Current Pandemics: COVID-19, Obesity and Malignancy
Prodromidou, A., Koulakmanidis, A.-M., Haidopoulos, D. A., Nelson, G. S., Rodolakis, A., & Thomakos, N. (2022) · Cancers · doi:10.3390/cancers14071660 · Cited by 6
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
He, X., & Zeng, X. X. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s347297 · Cited by 7
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
Margalit, O., Shacham-Shmueli, E., Itay, A., Berger, R., Halperin, S., Jurkowicz, M., Levin, E. G., Olmer, L., Regev-Yochay, G., Lustig, Y., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.03.013 · Cited by 6
Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT
Minamimoto, R., Hotta, M., Okafuji, T., Tsutui, S., Tsukuda, M., Nakayama, H., Shida, Y., & Tajima, T. (2022) · Global Health & Medicine · doi:10.35772/ghm.2022.01016 · Cited by 6
Critical Influenza and COVID-19—A Comparative Nationwide Case-Control Study
Larsson, E., Eriksson, J., Eriksson, M., & Oldner, A. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000705 · Cited by 6
Delirium in Critically Ill Cancer Patients With COVID-19
Bjerre-Real, C., Dhawan, V., Sharma, M., Seier, K., Tan, K. S., Matsoukas, K., Maloy, M., Voigt, L. P., Alici, Y., & Chawla, S. (2022) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2022.05.005 · Cited by 6
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer
İriağaç, Y., Çavdar, E., Karaboyun, K., Avcı, O., Alan, Ö., Taşkaynatan, H., Çelikkol, A., Kara, S. P., Erdal, B., & Seber, S. (2022) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2022_063 · Cited by 6
Bio‐ethical issues in oncology during the first wave of the COVID‐19 epidemic: A qualitative study in a French hospital
Stoeklé, H., Ladrat, L., Landrin, T., Beuzeboc, P., & Hervé, C. (2022) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13766 · Cited by 6
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ataei, A., Derakhshan, M. M., Razmjooie, M., Zare, F., Amiresmaeili, H., Salehi, N., Namakkoobi, N., Mirhosseini, H., Karim, B., & Iravani, S. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1954-5605 · Cited by 6
COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study
Valvi, N. R., Patel, H., Bakoyannis, G., Haggstrom, D. A., Mohanty, S., & Dixon, B. E. (2022) · JMIR Cancer · doi:10.2196/35310 · Cited by 6
Viral infections in pediatric brain tumor patients treated with targeted therapies
Mayr, L., Steinmaurer, T., Weseslindtner, L., Madlener, S., Straßl, R. P., Gojo, J., Azizi, A. A., Slavc, I., & Peyrl, A. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.30065 · Cited by 6
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer
Powis, M., Sutradhar, R., Patrikar, A., Cheung, M. C., Gong, I. Y., Vijenthira, A., Hicks, L. K., Wilton, D., Krzyzanowska, M. K., & Singh, S. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac204 · Cited by 6
A differential process mining analysis of COVID-19 management for cancer patients
Cuendet, M. A., Gatta, R., Wicky, A. M., Gerard, C. L., Dalla‐Vale, M., Tavazzi, E., Michielin, G., Delyon, J., Cesbron, J., Lofek, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1043675 · Cited by 6
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
Williams, L. A., Whisenant, M., Mendoza, T. R., Peek, A., Malveaux, D., Griffin, D., Ponce, D. A., Granwehr, B. P., Sheshadri, A., Hutcheson, K. A., et al. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00591-x · Cited by 6
Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among Chinese cancer patients: A multicentre cross-sectional survey
Zhang, L., Yang, J., Su, R., Du, X., Wang, Y., Chen, S., Chan, P. S.-F., Wang, Z. J., & Xu, J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2222648 · Cited by 6
Self-citation
COVID-associated complications after reconstructive breast surgery: a retrospective cohort study
Bubberman, J. M., Claessen, J. J. M., Feijen, M. M. W., Meesters-Caberg, M. A. J., van Kuijk, S. M. J., van der Hulst, R. R. W. J., & Tuinder, S. M. H. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07064-1 · Cited by 6
Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study
da Silva, J. L., de Souza, B. S. W., de Albuquerque, L. Z., Aleixo, S. B., Resende, G. A. D. S., de Oliveira, D. G. B., dos Santos, E. N., Nogueira‐Rodrigues, A., Clara, R. O., Gauí, M. D. F. D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295597 · Cited by 6
Risk of COVID-19 in Patients With Cancer—Reply
Chua, M. L. K., Yu, J., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2589 · Cited by 6
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response Taskforce
Kwek, J. W., Chan, J. J., Kanesvaran, R., Wang, M. L. C., Neo, P. S. H., Chia, C. S., Tham, C. K., Chew, L. S. T., Tan, H. K., Yap, S. P., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00535 · Cited by 6
Management of lung cancer in the COVID-19 pandemic: a review
Piñeiro, F. M., López, C. T., & Aguado, J. D. L. F. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.115 · Cited by 5
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers
Shumilov, E., Hoffknecht, P., Koch, R., Peceny, R., Voigt, S., Schmidt, N. C., Peeck, M., Bacher, U., Scheithauer, S., Trümper, L. H. P., et al. (2021) · Cancers · doi:10.3390/cancers13122917 · Cited by 6
Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
Allali, S., Beddok, A., & Kirova, Y. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.06.015 · Cited by 6
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
Fazio, N., Gervaso, L., Halfdanarson, T. R., Salvia, A. L., Hofland, J., Hernando, J., Sonbol, M. B., García‐Carbonero, R., Capdevila, J., de Herder, W. W., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.029 · Cited by 6
Clinical outcomes in cancer patients with COVID-19 in Sweden
Bondeson, L., Thulin, A., Ny, L., Levin, M., Svensson, J., Lindh, M., & Zhao, Z. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1973679 · Cited by 6
COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature
Patel, R. H., Vanaparthy, R., & Greene, J. N. (2021) · Cancer Control · doi:10.1177/10732748211044361 · Cited by 6
Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic
Webber, T. B., Giuliano, S., Patrone, C., Briata, I. M., Franconeri, M., Marceca, F., Magnani, M., Paciolla, F., Provinciali, N., Defferrari, C., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010913 · Cited by 6
Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma
Xiao, L., Chen, Y., & Fan, Y. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17321-9 · Cited by 6
Self-citation
Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy
Rugge, M., Zorzi, M., Guzzinati, S., Stocco, C. F., Avossa, F., Zotto, S. D., Clagnan, E., Bricca, L., Maso, L. D., & Serraino, D. (2022) · Tumori Journal · doi:10.1177/03008916211073771 · Cited by 6
Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines
Son, C.-S., Jin, S. H., & Kang, W. (2022) · Vaccines · doi:10.3390/vaccines10020284 · Cited by 6
Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed Surgeries
Eskander, A. E., Li, Q., Yu, J., Hallet, J. I., Coburn, N. G., Dare, A. J., Chan, K., Singh, S., Parmar, A., Earle, C. C., et al. (2022) · Current Oncology · doi:10.3390/curroncol29030153 · Cited by 6
Covid-19 in pediatric hematology-oncology and stem cell transplant patients –The spectrum of illness, complications and comparison of first two waves
Bhayana, S., Kalra, M., & Sachdeva, A. (2022) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2022.05.003 · Cited by 6
Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19
Cury, S. S., Oliveira, J. S., de Biagi, C. A. O., Silva, W. A., Reis, P. P., Cabral-Marques, O., Hasimoto, É. N., Freire, P. P., & Carvalho, R. F. (2022) · Gene · doi:10.1016/j.gene.2022.147047 · Cited by 6
COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
Joharatnam‐Hogan, N., & Khan, K. H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01649-z · Cited by 6
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience
Cui, W., Yousaf, N., Bhosle, J., Minchom, A. R., Nicholson, A. G., Ahmed, M., McDonald, F., Locke, I., Lee, R., O'Brien, M. E. R., et al. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100261 · Cited by 6
Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series
Preda, A., Ciuleanu, T., Kubelac, P. M., Todor, N., Bălăcescu, O., Achimaș-Cădariu, P., Iancu, D., Mocan, C. M., Bandi-Vasilica, M., Lupșe, M. S., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100423 · Cited by 6
The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations
Prasad, K., Gour, P., Raghuvanshi, S., & Kumar, V. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.200 · Cited by 6
Radionuclide therapy in the time of COVID-19
Brabander, T., & Hofland, H. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04921-9 · Cited by 6
Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy
Singh, M. K., Jain, M., Shyam, H., Shankar, P., & Singh, V. (2021) · VirusDisease · doi:10.1007/s13337-021-00742-y · Cited by 6
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: A systematic review with meta-analysis involving 709.908 participants and 31.732 cancer patientsPreprint
Arayıcı, M. E., Kipcak, N., Kayacik, U., Kelbat, C., Keskin, D., Kilicarslan, M. E., Kilinc, A. V., Kirgoz, S., Kirilmaz, A., Kizilkaya, M. A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1707569/v1 · Cited by 6
Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study
Kathuria‐Prakash, N., Antrim, L. J., Hornstein, N. J., Sun, A. W., Kang, I. M., Baclig, N. V., Angell, T. E., Lechner, M. G., Wald‐Dickler, N., & In, G. K. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.12.005 · Cited by 5
Current issues of post-covid syndrome consequences
Krasnoselskyi, M. V., Starenkyі, V. P., Artamonova, N. O., Kulinich, H. V., Prokhorova, E. B., & Havrylenko, M. V. (2023) · Український радіологічний та онкологічний журнал · doi:10.46879/ukroj.3.2023.325-352 · Cited by 5
Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures
Sim, J.-A., Shin, J. H., Lee, H. J., Lee, Y.-S., & Kim, Y. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296808 · Cited by 5
Conquering dual challenges: A sialic acid-modified liposome for targeting activated neutrophils to tackle comorbid lung inflammation and cancer metastasis
Li, C., Li, Z., Wang, L., Zhang, K., Li, Z., Ji, Y., Li, J., Zhang, Y., & Chen, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.048 · Cited by 6
Self-citation
The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies
Naffaa, M. M., & Al-Ewaidat, O. A. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001314 · Cited by 7
COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society
Köktürk, N., İtil, B. O., Altınışık, G., Adıgüzel, N., Akgün, M., Akyıldız, L., Altın, S., Arıkan, H., Ateş, G., Ay, P., et al. (2020) · Turkish Thoracic Journal · doi:10.5152/turkthoracj.2020.20174 · Cited by 5
Cancer treatment in the coronavirus disease pandemic
Zhang, J., Zhong, W., & Wu, Y.-L. L. C. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.12.012 · Cited by 7
Is COVID-19 a high risk factor for lung cancer?
Wu, M., Mou, R., Liu, X., Guo, S., Kong, F., Li, X., & Jia, Y. (2021) · Medicine · doi:10.1097/md.0000000000023877 · Cited by 5
Self-citation
Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience
Calvo, V., Fernández‐Cruz, A., Núñez, B., Blanco, M., Morito, A., Martínez, M., TRASEIRA, C., Garitaonaindía, Y., Aguado, R., Ramos, A., et al. (2021) · Clinical Epidemiology · doi:10.2147/clep.s308437 · Cited by 5
The Effects of Sex Hormones and some Respiratory Diseases on the Severity of Corona Virus Infection
Al-Kurdy, M. J. J., Abbas, G. A., & Kazaal, M. A. (2022) · Bionatura · doi:10.21931/rb/2022.07.02.13 · Cited by 5
Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial
Parikh, R. B., Ferrell, W. J., Wakim, J., Williamson, J., Khan, N., Kopinsky, M., Balachandran, M., Gabriel, P. E., Zhang, Y., Schuchter, L. M., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054675 · Cited by 5
Self-citation
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
Faucheux, L., Alves, L. B. D. O., Chevret, S., & Rocha, V. (2022) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2022.05.003 · Cited by 5
Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach
Hu, C., Dai, Y., Zhou, H., Zhang, J., Xie, D., Xu, R., Yang, M., & Zhang, R. (2022) · Hereditas · doi:10.1186/s41065-022-00258-5 · Cited by 5
An Assessment of Extended Pembrolizumab Dosing in Advanced Non-Small-Cell Lung Cancer in the Covid-19 Pandemic
Moffat, G. T., Hanna, L., Hopman, W. M., Fung, A. S., & Gaudreau, P.-O. (2023) · Immunotherapy · doi:10.2217/imt-2022-0257 · Cited by 5
Exploring the Potential Association between COVID-19 and Thyroid Cancer: A Mendelian Randomization Study
Xu, D., Wang, X., & Zhou, D. (2023) · ACS Omega · doi:10.1021/acsomega.3c07287 · Cited by 5

Authors: Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
Affiliations: Zhongnan Hospital of Wuhan University (CN)
Boston Children's Hospital (US)
Brigham and Women's Hospital (US)
Wuhan Union Hospital (CN)
Central Hospital of Wuhan (CN)
Huanggang Central Hospital (CN)
Guangzhou Medical University (CN)
Tongji Hospital (CN)
16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Hubei Cancer Hospital (CN)
Renmin Hospital of Wuhan University (CN)
19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
Xianning Central Hospital (CN)
The Central Hospital of Xiao gan (CN)
22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
Hubei University of Medicine (CN)
Harvard University (US)
Corresponding author: Liu, Miao
Santillana, Mauricio
Cai, Hongbing
ORCID: Liu, Dianbo
Liu, Miao
Zhou, Fuxiang
Li, Guiling
Chen, Zhen
You, Hua
Wu, Meng
Xiong, Yong
Xiong, Huihua
Wang, Chun
Xiong, Fei
Zhang, Yan
Yu, Tingting
Wang, Ling
Wang, Hua
Liu, Yu
Li, Zhuyan
He, Can
Shi, Yuying
Qi, Yuwen
Yang, Jing
Tenen, Daniel G.
Chai, Li
Mucci, Lorelei A.
Santillana, Mauricio
Cai, Hongbing
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2020-06-01
Volume: 10
Issue: 6
Pages: 783-791
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-20-0422
PMC: PMC7309152
OpenAlex: W3015599879
Cited by: 1,589
References: 27
Citations by year: 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
FWCI: 128.41
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Discovery (publishedVersion)
SSRN Electronic Journal (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (8197103302/H16)
Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
NIH NHLBI (P01HL095489)
Xiu Research Fund
Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
Topics: Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
Keywords: COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks